Trident Lifeline Limited's shareholding in subsidiary Trident Mediquip Limited has decreased from 60.04% to 57.34% following a private placement of equity shares to other shareholders. Trident Mediquip, incorporated in 2019, operates in the pharmaceuticals and chemical industry with a current turnover of 21.29 crores and paid-up share capital of Rs. 9.78 crores. The transaction has been disclosed under SEBI regulations as a related party transaction conducted on an arm's length basis.
Trident Lifeline's Shareholding in Subsidiary Trident Mediquip Reduces to 57.34% After Private Placement
Trident Lifeline Limited has reported a reduction in its shareholding in subsidiary Trident Mediquip Limited following a private placement transaction. The company's stake in the subsidiary has decreased from 60.04% to 57.34% after Trident Mediquip Limited allotted equity shares to other shareholders.
Shareholding Change Details
The change in shareholding occurred due to a private placement of equity shares by Trident Mediquip Limited to other shareholders. This transaction has resulted in a dilution of Trident Lifeline's ownership stake in its subsidiary.
Parameter: Details Pre-holding: 60.04% Post-holding: 57.34% Transaction Type: Private Placement Regulatory Filing: Under Regulation 30 of SEBI (LODR)
About Trident Mediquip Limited
Trident Mediquip Limited is a subsidiary company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry and was incorporated on October 19, 2019.
Financial Structure
Financial Parameter: Amount Authorized Share Capital: Rs. 10.00 crores Paid-up Share Capital: Rs. 9.78 crores Number of Equity Shares: 97,75,800 shares Face Value per Share: Rs. 10 Current Turnover: 21.29 crores
Historical Performance
Trident Mediquip Limited's turnover performance over the last three financial years shows:
Financial Year: Turnover 2022-23: 28.77 crores 2023-24: 20.58 crores 2024-25: 21.29 crores
Related Party Transaction
The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. The filing indicates that several promoters and directors of Trident Lifeline Limited, including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai, have interests in the subsidiary. The company has confirmed that the transaction is being undertaken on an arm's length basis.
Regulatory Compliance
Trident Lifeline Limited has filed the necessary disclosures under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also complied with SEBI Master Circular requirements in making this announcement to the stock exchanges.
Trident Lifeline Limited has received a disclosure from Hardik Desai Family Trust regarding the acquisition of additional shares under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trust, operating through its Ultimate Beneficial Owner Hardik Jigishkumar Desai, belongs to the promoter group category.
Share Acquisition Details
The trust acquired 1,200 shares through open market purchase on 20.02.2026. This transaction represents a minimal increase of 0.01% in both total share capital and diluted share capital terms.
Transaction Details: Value Shares Acquired: 1,200 Acquisition Mode: Open Market Transaction Date: 20.02.2026 Percentage Increase: 0.01%
Holdings Comparison
The acquisition resulted in a marginal increase in the trust's shareholding position in the company.
Holding Period: Number of Shares % of Total Capital % of Diluted Capital Before Acquisition: 8,32,766 6.98% 6.66% After Acquisition: 8,33,966 6.99% 6.67% Net Change: +1,200 +0.01% +0.01%
Company Capital Structure
Trident Lifeline Limited maintains a stable capital structure with no changes reported in the equity share capital following this transaction.
Capital Component: Details Equity Share Capital: Rs. 11,93,30,000 Number of Equity Shares: 1,19,33,000 Face Value per Share: Rs. 10 Total Diluted Capital: Rs. 12,49,34,000 Diluted Shares: 1,24,93,400
The disclosure was filed in compliance with SEBI regulations, with the company's shares listed on BSE Limited. The trust's registered address is located at 01 Seema Row House, Ghod Dod Road, Umra, Surat City, Gujarat.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.